P
Prometheus Biosciences
Committed to the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune disease
At a glance
- Status
- Listed
- Listing
- IPO 2021
News
Open roles
Prometheus Biosciences in the San Diego ecosystem
The Prometheus Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later10 investors entered at this stage
- AIAscend Global Investments
- NENestlé
- CGCowen Group
- RIRTW Investments
- EMEventide Asset Management
Perceptive Advisors- CCCormorant Capital
- CECedars-Sinai
- IIIrving Investors
- POPoint72
Source: Dealroom Talent Intelligence.
Alumni founders
Former Prometheus Biosciences employees who went on to found companies, sorted by Dealroom signal score.
MTMirador TherapeuticsEst. 2024
PPPhathom PharmaceuticalsEst. 2018
David SocksUnited States
SASantarusEst. 1996
Scott GlennUnited States
SBShoreline BiosciencesEst. 2020
William SandbornUnited StatesGlobal footprint
Patents
57 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Prometheus Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


